Medical aethetics co. BioForm Medical prices IPO below range, raises up to $92M

See our story about this San Mateo, Calif., wrinkle-filler maker in today’s daily briefing at VentureBeat Life Sciences.

Next Story: Aryx discounts IPO price, raises up to $58M for safer drugs
Previous Story: Roundup: Yahoo’s China troubles, Google’s game ads, and more

Bookmark and Share
Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.